Skip to main content
Signatory to the global Responsible Care initiative|ISO 9001 · ISO 14001 · ISO 45001 · ISO 50001
Enquire
Board of Directors

Leadership and governance

Transpek focuses on high standards of corporate governance, based on ethical values and principles, as a stated part of our mission.

The Board

Composition

The board comprises executive and independent non-executive directors, with committees for audit, nomination and remuneration, stakeholder relationship and corporate social responsibility.

To be suppliedDirector names, designations (Chairman, Managing Director, Independent Director), DIN numbers, photographs and short biographies. Once supplied, each director becomes a card in the grid below. Board committee membership tables should be added under this section, and kept in step with the disclosures on the Investors pages.

Director name

Designation

Short biography, qualifications and other directorships.

Director name

Designation

Short biography, qualifications and other directorships.

Director name

Designation

Short biography, qualifications and other directorships.

Governance

How we are governed

As a listed company, Transpek publishes its corporate governance report, board committee composition, related-party transaction policy, code of conduct and whistle-blower policy. These are maintained on the Investors pages alongside our financial results.

Policies and investor information

Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee and Corporate Social Responsibility Committee. Composition and terms of reference are published in the annual report.

A code of conduct applies to directors and senior management, covering conflicts of interest, confidentiality, insider trading and fair dealing.

A vigil mechanism allows employees and directors to report genuine concerns, with direct access to the chairman of the Audit Committee.

Shareholder grievances are handled by the Company Secretary and monitored by the Stakeholders Relationship Committee. See the Investor Grievances page for the escalation route.